Literature DB >> 22851457

Glutamate gene polymorphisms predict brain volumes in multiple sclerosis.

Eva M M Strijbis1, Becky Inkster, Maria Vounou, Yvonne Naegelin, Ludwig Kappos, Ernst-Wilhelm Radue, Paul M Matthews, Bernard M J Uitdehaag, Frederik Barkhof, Chris H Polman, Giovanni Montana, Jeroen J G Geurts.   

Abstract

BACKGROUND: Several genetic markers have been associated with multiple sclerosis (MS) susceptibility; however, uncovering the genetic aetiology of the complex phenotypic expression of MS has been more difficult so far. The most common approach in imaging genetics is based on mass-univariate linear modelling (MULM), which faces several limitations.
OBJECTIVE: Here we apply a novel multivariate statistical model, sparse reduced-rank regression (sRRR), to identify possible associations of glutamate related single nucleotide polymorphisms (SNPs) and multiple MRI-derived phenotypes in MS.
METHODS: Seven phenotypes related to brain and lesion volumes for a total number of 326 relapsing-remitting and secondary-progressive MS patients and a total of 3809 glutamate related and control SNPs were analysed with sRRR, which resulted in a ranking of SNPs in decreasing order of importance ('selection probability'). Lasso regression and MULM were used as comparative statistical techniques to assess consistency of the most important associations over different statistical models.
RESULTS: Five SNPs within the NMDA-receptor-2A-subunit (GRIN2A) domain were identified by sRRR in association with normalized brain volume (NBV), normalized grey matter volume and normalized white matter volume (NMWM). The association between GRIN2A and both NBV and NWMV was confirmed in MULM and Lasso analysis.
CONCLUSIONS: Using a novel, multivariate regression model confirmed by two other statistical approaches we show associations between GRIN2A SNPs and phenotypic variation in NBV and NWMV in this first exploratory study. Replications in independent datasets are now necessary to validate these findings.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22851457     DOI: 10.1177/1352458512454345

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  10 in total

1.  Mapping of thalamic magnetic susceptibility in multiple sclerosis indicates decreasing iron with disease duration: A proposed mechanistic relationship between inflammation and oligodendrocyte vitality.

Authors:  Ferdinand Schweser; Ana Luiza Raffaini Duarte Martins; Jesper Hagemeier; Fuchun Lin; Jannis Hanspach; Bianca Weinstock-Guttman; Simon Hametner; Niels Bergsland; Michael G Dwyer; Robert Zivadinov
Journal:  Neuroimage       Date:  2017-10-31       Impact factor: 6.556

Review 2.  Network collapse and cognitive impairment in multiple sclerosis.

Authors:  Menno M Schoonheim; Kim A Meijer; Jeroen J G Geurts
Journal:  Front Neurol       Date:  2015-04-14       Impact factor: 4.003

3.  Mapping the genetic variation of regional brain volumes as explained by all common SNPs from the ADNI study.

Authors:  Christopher Bryant; Kelly S Giovanello; Joseph G Ibrahim; Jing Chang; Dinggang Shen; Bradley S Peterson; Hongtu Zhu
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

4.  Effect of teriflunomide on cortex-basal ganglia-thalamus (CxBGTh) circuit glutamatergic dysregulation in the Theiler's Murine Encephalomyelitis Virus mouse model of multiple sclerosis.

Authors:  Claire M Modica; Ferdinand Schweser; Michelle L Sudyn; Nicola Bertolino; Marilena Preda; Paul Polak; Danielle M Siebert; Jacqueline C Krawiecki; Michele Sveinsson; Jesper Hagemeier; Michael G Dwyer; Suyog Pol; Robert Zivadinov
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

5.  Neuronal metabotropic glutamate receptor 8 protects against neurodegeneration in CNS inflammation.

Authors:  Marcel S Woo; Friederike Ufer; Nicola Rothammer; Giovanni Di Liberto; Lars Binkle; Undine Haferkamp; Jana K Sonner; Jan Broder Engler; Sönke Hornig; Simone Bauer; Ingrid Wagner; Kristof Egervari; Jacob Raber; Robert M Duvoisin; Ole Pless; Doron Merkler; Manuel A Friese
Journal:  J Exp Med       Date:  2021-05-03       Impact factor: 14.307

Review 6.  Engine Failure in Axo-Myelinic Signaling: A Potential Key Player in the Pathogenesis of Multiple Sclerosis.

Authors:  Talia Bergaglio; Antonio Luchicchi; Geert J Schenk
Journal:  Front Cell Neurosci       Date:  2021-02-10       Impact factor: 5.505

7.  Functional enrichment of alternative splicing events with NEASE reveals insights into tissue identity and diseases.

Authors:  Markus List; Olga Tsoy; Zakaria Louadi; Maria L Elkjaer; Melissa Klug; Chit Tong Lio; Amit Fenn; Zsolt Illes; Dario Bongiovanni; Jan Baumbach; Tim Kacprowski
Journal:  Genome Biol       Date:  2021-12-02       Impact factor: 13.583

Review 8.  Secondary Prevention in Radiologically Isolated Syndromes and Prodromal Stages of Multiple Sclerosis.

Authors:  Maria Pia Amato; Nicola De Stefano; Matilde Inglese; Emanuele Morena; Giovanni Ristori; Marco Salvetti; Maria Trojano
Journal:  Front Neurol       Date:  2022-03-14       Impact factor: 4.003

9.  Pathoetiology of multiple sclerosis: are we barking up the wrong tree?

Authors:  Peter K Stys
Journal:  F1000Prime Rep       Date:  2013-06-03

Review 10.  Recent advances in understanding multiple sclerosis.

Authors:  Peter K Stys; Shigeki Tsutsui
Journal:  F1000Res       Date:  2019-12-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.